Dr. Zakir Khan : Leading Researcher in Myeloid cell function

professor at  Cedars-Sinai Medical Center, United States

Congratulations, Dr. Zakir Khan, on winning the esteemed Best Researcher Award from pencis! Your dedication, innovative research, and scholarly contributions have truly made a significant impact in your field. Your commitment to advancing knowledge and pushing the boundaries of research is commendable. Here’s to your continued success in shaping the future of academia and making invaluable contributions to your field. Well done!

Professional Profile

Google Scholar Profile

Education:

• Ph.D. (2009) : Biotechnology (Cancer Biology), Bundelkhand University Jhansi, India
• M.Sc. (2001) : Biochemistry, Jiwaji University Gwalior, India.
• B.Sc. (1999) : Biology Major (Zoology, Botany, Chemistry), Jiwaji University Gwalior, India

Positions and Scientific Appoitments

• 2019 – Assistant Professor of Pathology, Cedars-Sinai Medical Center, Los Angeles, CA
• 2019 – Assistant Professor of Biomedical Sciences, Cedars-Sinai Medical Center, Los Angeles, CA
• 2019 – Research Scientist I, Cedars-Sinai Medical Center, Los Angeles, CA
• 2022 – Member, American Society of Hematology (ASH)
• 2018 – Member, American Heart Association (AHA)
• 2018 – 2019 Member, American Society for Biochemistry and Molecular Biology (ASBMB)
• 2015 – 2018 Project Scientist, Cedars-Sinai Medical Center, Los Angeles, CA
• 2013 – 2014 Member, The French Society for Biochemistry and Molecular Biology (SFBBM)
• 2013 – 2014 Postdoc, Institute Curie, Paris, France

Teaching Activities:

• 2019 – Cedars-Sinai Medical Center; 5% Effort Courses: Immunology, Biochemistry and Cardiovascular Physiology
• 2003 – 2007 Madhav Institute of Technology & Science (MITS) Gwalior, India; 5% Effort Courses: Biochemistry and Molecular Biology – BS and MS level.
• 2002 – 2003 GICTS Group of Colleges, Gwalior, India; 90% Effort Courses: Biochemistry, Enzymology, and Molecular Biology – BS and MS level.
• 2001 – 2002 Subhash Chandra Bose College, Gwalior, India; 90% Effort Courses: Biochemistry, Enzymology, and Molecular Biology – BS and MS level.

Honors and Awards:

• 2022 – Board Member, “Cancer Advances”, ISSN 2815-7125
• 2022 Advisory committee member, 2nd Int-BIONANO Conference 2022, Amity Uni., Gwalior
• 2021 Cedars-Sinai Academic Pathology Minigrant Award (COVID-19 Research) 2020 Cedars-Sinai Academic Pathology Minigrant Award (Cancer Research)
• 2019 Career Development Award – American Heart Association (3 years grant)
•  2019 – 2021 Board Member, “Cellular & Molecular Biology Letters”, ISSN 1689-1392
• 2018 – 2020 Research consultant (honorary), Innoscience Research, Selangor, Malaysia
• 2016 – Editorial Board Member, “Journal of Solid Tumors”, ISSN 1925-4067
• 2013 Young Investigator Award – Institute Curie (1 year fellowship)
• 2012 – 2014 Guest Editor, Special issue “Current Medicinal Chemistry”, ISSN: 0929-8673

Peer-Reviewed Papers:

•  Total Journal Impact Factor : 498
• Total Citations : 3278
•  h-index : 26 i10
•  index : 40

Publications top noted:

Nutritional and therapeutic potential of Spirulina ( cited by- 672- year -2005)

Structural, functional and therapeutic biology of survivin

Angiotensin-converting enzyme in innate and adaptive immunity

Biology of Cox-2: an application in cancer therapeutics

Slow CCL2-dependent translocation of biopersistent particles from muscle to brain

Survivin, a molecular target for therapeutic interventions in squamous cell carcinoma

Oncoapoptotic signaling and deregulated target genes in cancers: special reference to oral cancer

Cardiac troponins I and T: molecular markers for early diagnosis, prognosis, and accurate triaging of patients with acute myocardial infarction

Detection of survivin and p53 in human oral cancer: correlation with clinicopathologic findings